- Nobel-winning physicist 'unnerved' by AI technology he helped create
- Mexico president rules out new 'war on drugs'
- Israeli defense minister postpones trip to Washington: Pentagon
- Europe skipper Donald in talks with Garcia over Ryder return
- Kenya MPs vote to impeach deputy president in historic move
- Former US coach Berhalter named Chicago Fire head coach
- New York Jets fire head coach Saleh: team
- Australia crush New Zealand in Women's T20 World Cup
- US states accuse TikTok of harming young users
- 'Evacuate now, now, now': Florida braces for next hurricane
- US Supreme Court skeptical of challenge to 'ghost guns' regulation
- Sparks fly as Orban berates EU 'elites' in parliament trip
- US finalizes rule to remove lead pipes within a decade
- Solanke hungry for second England cap after seven-year wait
- Gilded canopy restored at Vatican basilica
- Zverev scrapes through, Djokovic cruises to Shanghai Masters last 16
- Trump secretly sent Covid tests to Putin: Bob Woodward book
- Gauff answers critics: 'It's hard to win all the time'
- Neural networks, machine learning? Nobel-winning AI science explained
- China says raised 'serious concerns' with US over trade curbs
- Boeing delivers 27 MAX jets in September despite strike
- German 'Maddie' suspect could be free in 2025 after cleared of other sex crimes
- Italy seek Nations League consistency as Germany continue rebuild
- From boom to budgeting as reality bites for Saudi football
- Stock markets diverge as Hong Kong sinks, oil prices fall
- US trade gap narrowest in five months as imports slip
- Stay and 'you are going to die': Florida braces for next hurricane
- England 96-1 after Salman's century lifts Pakistan to 556
- Hollywood star Idris Elba champions African cinema in Ghana
- Djokovic rolls Cobolli to make Shanghai Masters last 16
- Milan's Hernandez receives two-game suspension after referee rant
- Geoffrey Hinton, soft-spoken godfather of AI
- Ex-Barcelona and Spain great Iniesta retires aged 40
- Duo wins Physics Nobel for 'foundational' AI breakthroughs
- German 'Maddie' suspect could be free in 2025 after cleared of separate sex crimes
- China slaps provisional tariffs on EU brandy imports
- Ex-skipper Skelton eyes Wallabies November return
- Spanish great Iniesta leaves indelible legacy after retirement
- Indian Kashmir elects first regional government in a decade
- Hong Kong stocks crash, oil prices retreat on fading China boost
- Man City accuse Premier League of 'misleading' claims after legal case
- Duo wins Physics Nobel for key breakthroughs in AI
- Agha defies England as Pakistan post 515-8 in first Test
- September second-warmest on record: EU climate monitor
- Pastor wanted by US for sex trafficking to run for Philippine senate
- Mozambican writer Mia Couto dreams future leaders set an 'example'
- German 'Maddie' suspect could be free soon after cleared of separate sex crimes
- China says to take anti-dumping measures against EU brandy imports
- German suspect in 'Maddie' case cleared in separate sex crimes trial
- Israel expands offensive against Hezbollah in south Lebanon
RBGPF | -0.46% | 60.52 | $ | |
CMSC | 0.29% | 24.641 | $ | |
SCS | -1.33% | 12.78 | $ | |
RYCEF | 1.29% | 6.97 | $ | |
NGG | 0.61% | 65.88 | $ | |
RELX | 1.27% | 46.63 | $ | |
BP | -3.5% | 32.02 | $ | |
RIO | -4.42% | 66.675 | $ | |
GSK | -1.59% | 38.026 | $ | |
BTI | 0.04% | 35.215 | $ | |
BCE | -0.03% | 33.52 | $ | |
VOD | -0.31% | 9.66 | $ | |
BCC | 0.56% | 142.06 | $ | |
AZN | 0% | 76.87 | $ | |
CMSD | 0.25% | 24.851 | $ | |
JRI | -0.15% | 13.16 | $ |
Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
S.Gregor--AMWN